|
|
In the Health Center COVID-19 Survey you will receive next week, we are adding questions about participation in the HRSA Health Center COVID-19 Therapeutics Program. Please note that the initial phase of this program includes a limited number of health centers.
- The first question will ask if your health center provided COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program to patients. (If your health center is not yet participating, you will answer No.)
- For anyone who answers Yes, you will next be asked to report on how many patients received a course by race and ethnicity and then by special population.
We will update the Survey User Guide by noon on Friday, January 14.
|
|
|
|
Sign up for eNews
Connect with HRSA
